Company Filing History:
Years Active: 2017
Title: Hervè Blumstein: Innovator in Heart Failure Therapy
Introduction
Hervè Blumstein is a notable inventor based in Mèvoisins, France. He has made significant contributions to the field of medical technology, particularly in the area of heart failure therapy. His innovative approach focuses on the use of active implantable medical devices to improve patient outcomes.
Latest Patents
Hervè Blumstein holds a patent for an "Active implantable medical device for heart failure therapy with stochastic stimulation of the vagus nerve." This patent describes a method for heart treatment that includes analyzing the cardiac rhythm. The method utilizes a generator to produce discharges of N pulses of vagus nerve stimulation (VNS) in succession. The discharge is synchronized to a detected R ventricular depolarization wave of each cardiac cycle. Furthermore, the method controls a stochastic modulation of the discharges, allowing for variability in the number of pulses delivered. This innovative therapy is applied when the spontaneous heart rate variability falls below a minimum level.
Career Highlights
Hervè Blumstein is associated with Sorin Crm Sas, a company that specializes in medical devices. His work at Sorin Crm Sas has allowed him to focus on developing advanced solutions for heart failure therapy. His dedication to improving patient care through technology is evident in his innovative patent.
Collaborations
Hervè collaborates with Thierry Legay, contributing to the advancement of medical technology and the development of effective therapies for heart conditions.
Conclusion
Hervè Blumstein's contributions to heart failure therapy through his innovative patent demonstrate his commitment to improving healthcare. His work continues to influence the field of medical technology, providing hope for patients with heart conditions.